Centrum Private Credit Fund - Annual NewsLetter
Centrum Private Credit Fund - Annual NewsLetter
Centrum Private Credit Fund - Annual NewsLetter
Dear Investors
We are pleased to bring to you this annual newsletter highlighting the Fund’s performance for Rakshat Kapoor
the year ended March 31st, 2022. CIO & Fund Manager
46.6
We launched our first Credit Fund in 2018-19 to prepare for an increased need for bespoke CIO
capital solutions in a dynamic and potentially less benign environment. Since then, we have Rakshat Kapoor has over 20 plus years
witnessed a debt crisis in India, been hit by the pandemic and are now hamstrung by inflation of experience in Private Credit. Prior to
and burgeoning asset prices. The ongoing war which is now in the 3rd month with no immediate Centrum Private Credit Fund, he was
signs of abatement has led to a very uncertain and turbulent geopolitical situation. But as Seth with Nomura Securities where he
Klarman puts it “Unprecedented events occur with some regularity, so be prepared”. As a result, worked in Private Credit, Debt Capital
we continue to be prudent in our approach and recalibrate our risk methodologies. Markets & Investment Banking
Divisions. Prior to that, he was with
Deutsche Bank’s structured credit
investments and ICICI Bank’s
Fund Performance structured finance team.
Key updates on our Fund performance are as follows:
We have completed 3.5 years of the investment period and have made 13 investments till
date. The total invested capital is INR 1,440 crore across the Fund and Co-invested Capital
Fund Statistics as on Mar 31, 2022
We have exited 8 of these investments, mostly before scheduled maturities validating the
First Close 30th Sep 2019
strength of our investment thesis and investment selection
Final Close 31st Mar 2022
The underlying credit quality in the investment portfolio continues to be satisfactory so far
Gross Invested Capital 1,440
without any delays or delinquencies
Fund Investments* 517
The Fund Level Gross IRR (internal rate of return) has been ~18% plus on a consistent Co-Investments 923
basis since inception Number of investments 13
Fund Gross IRR c.18%**
Fund Capital & Distribution Amounts in INR crore unless otherwise mentioned
* Includes reinvested capital
We are pleased to share that in line with the past quarters, the Fund is making a distribution **The Fund Gross IRR is pre expenses (management
fees and operating expenses) and carried interest
payout of 7% for Q4FY22. The remittance will be made within May 2022
We have announced the final close of the Fund on March 31 st, 2022 and have called for
drawdown of 100% of the capital commitments. We have a robust investment pipeline
spread across our target sectors, and are likely to have one or two more investments in
near term, or more investments should there be prepayments from the existing portfolio
The tenet of our investment strategy is to evaluate and identify key sectors that would benefit or are in line with the broader
macro economic outlook. We continue to believe sectors such as healthcare, pharma, packaging, logistics, specialty & agro
chemicals, and select domestic consumption themes, present attractive investment opportunities in the near term
Interest Rates: The rate cycle is on the upward trajectory and we have begun to see the rate hikes across central banks. In
India, we are in a better position compared to other geographies as the quantum of liquidity infusion was well calibrated. The
current GSec10Y at ~7.43% is now marginally above pre pandemic levels. We are bearish here and feel that the further hikes
in interest rates which would adjust now for inflation should be another 75 bps to 100bps and the 10Y would see a level of
~8% in 12-18 months. Usually, the Private Credit segment, to some extent, is price inelastic but we are cognizant of the
interest rates cycle, phased withdrawal of liquidity and repricing of assets. Accordingly, our ongoing investments will be priced
by keeping in mind the upward bias in the rates trajectory
Growth: The domestic economic indicators have started to show green shoots; increase in power consumption, steady
mobility trends, recovery in air traffic, people venturing out more etc. have ensured that the economy is heading steadily
towards pre-pandemic levels. Bank credit growth has also started to trend up. Further, Government initiatives on formalization
of economy, domestic manufacturing push, capex cycle etc will continue to be primary growth drivers. We are bullish on
overall growth and earnings. However, we feel that India will not be decoupled with global macro events and in near term,
will move in tandem
Private Credits as an asset class will continue to outperform and will garner lot of investor interest. The capital requirements
for corporate India would see an increase arising out of both private and public capital expenditure plans and enhanced
working capital demand. The global macro challenges may exacerbate the near term opportunities in the Private Credit
segment
Thank you for your continuous support and we appreciate your investment in our investments. We welcome any questions, or
comments you might have. You may contact me directly at private.credit@centrum.co.in.
Sincerely,
Rakshat Kapoor, Fund Manager & CIO
Page 1 of 17
Stricly Private & Confidential
Portfolio Summary
Note: 7% of capital commitments is paid each quarter Note: It includes all the 13 investments made till date
400
300 104
38
200
254 257
100
19
50
0
FY20 FY21 FY22
Principal Yield
Page 2 of 17
Stricly Private & Confidential
This is in furtherance to the investor communication dated December 16, 2021. An update has been provided below:
1. Extension of timeline in the Final Close date from September 30, 2021 to March 31, 2022:
We are pleased to inform yourselves that this extension has helped the Fund raise an additional capital of INR 69.75 crores
during this extended period. The total commitments as on final close of the Fund on 31 st March 2022 is at INR 362.25
crores.
2. Management fee to be calculated on Invested Capital instead of Drawn down capital, starting from Q3FY22:
The Investment Manager continues to charge management fees only on the drawn down capital (including for Q3FY22
and Q4FY22). The requisite information on management fees pertaining to each contributor will be computed and disclosed
in the periodic Statements of Account and NAV computation.
3. Disclosure of Fees:
The Investment Manager and, or its associates (as defined under the AIF Regulations) may or has received upfront fees
or any income from the portfolio companies and such fees or income have mostly been used towards securing co-
investments or facilitating down-selling of securities. These co-investments have helped the Investment Manager to
originate high quality credit transactions of large size. The down selling securities have also helped the Fund to reduce its
exposure to individual deals and diversify the risk at the portfolio level.
The year wise details of such income & expenses of the Investment Manager and its associates are as mentioned as
below:
Table 1: Details of income & expenses related to co-investments (INR crore)
Page 3 of 17
Stricly Private & Confidential
Sadbhav Engineering Limited (“Company / SEL”) is an infrastructure EPC company with presence
Investment Dates
in road, mining and irrigation segments. Historically, it built good track record in project execution
February – July 2021
for over three decades and has strong technical execution capabilities. The Company through its
subsidiary, Sadbhav Infrastructure Projects Limited (“SIPL”), as on March 22 owns 4 operational
Build-Operate-Transfer (BOT) assets and 10 under construction Hybrid Annuity Model (HAM)
projects. Sector
Infrastructure;Road EPC
Credit Updates
SEL’s standalone revenue declined by 27.6% YoY to INR 866 crore in 9MFY22. This was primarily Investment Amount
NCD – INR 155 crore
due to (i) stagnant order book (ii) Covid-19 related challenges, (iii) negative cash flow generations
leading to overall liquidity issues and poor execution of the existing orders due to lack of adequate
working capital.
Stagnant and slow moving order book Total Tenor – 3 years
Company has an order book position of INR 8,576 crore as on December 31, 2021. Average Maturity
However, a large proportion of the order book continues to remain slow moving; only 19% 30 months
and 9% of order book has been executed in FY21 and 9MFY22 respectively
In the last 12 months, the Company has not won any new orders and the execution per day Repayment Type
has been c.INR 3-4 crore versus a daily execution INR 8-9 crore (FY20 daily execution Amortizing over the
average).. Tenor
The group is planning to monetize Ahmedabad Ring Road Infrastructure Limited (ARRIL) and
three of its 3 HAM projects during FY23. The cash generation is expected to deleverage the
balance sheet and provide cash for operations
Sadbhav group has started commercial operations for 5 of its 10 hybrid annuity model (HAM)
projects and two more projects are likely to commence operations in Q2FY23. This may also
be monetized in near future
Page 4 of 17
Stricly Private & Confidential
Further, the group has entered into definitive agreements with Gawar Constructions Limited
(GCL; rated CARE AA-; Stable/ CARE A1+), either as a sponsor or as a contractor, to ramp
up the execution of the remaining three HAM assets. This should help in timely completion of
the projects.
Standalone Consolidated
INR crore 9MFY21 9MFY22 9MFY21 9MFY22
Income Statement
Revenue from operations 1,197 866 1,620 1,250
YoY (%) -28.1% -23.1%
Construction Expense 938 668 998 750
Gross Profit 259 198 622 500
Margin (%) 21.6% 22.8% 38.3% 40.0%
(i) All coupon payments due in FY22 (15 th June 2021, 15th September 2021,
15th Dec 2021 and 15th March 2022) have been paid on schedule dates
(ii) TDS and return filing has been done for Q1 and Q2 FY22. As on date, TDS
Credit Conditions for Q3 and Q4 is yet to be deposited.
& Compliances (iii) SEL was to ensure that its credit rating does not fall below “A-” by India
Ratings and “BBB+” by Care Ratings. The current rating of SEL is BBB+ by
India Ratings and CARE has rated BB+ and withdrawn the rating.
100
90
80
70
60
50
40
30
20
10
0
SEL SIPL
Fructification of above plans over INR 750 crore (monetization of MBCNL, ARRIL and 3 HAM
SPV’s) leading to substantial debt rationalisation and improvement in the liquidity on sustained
basis will be a key monitorable
Our view
The operational turnaround in the operating and financial metrics is taking longer time to
turnaround. This investment is under watch and we remain cautious.
Page 6 of 17
Stricly Private & Confidential
Wockhardt Limited
Wockhardt Limited (“Company”) is an established Indian pharmaceutical and biotechnology Investment Date
company. The main business operations comprise developing, manufacturing and marketing April – May 2021
of finished dosage and biopharmaceutical formulations, active pharmaceutical ingredients
(APIs) and vaccines. It has capabilities to produce sterile (injectable), biopharmaceuticals, Sector
orals (tablets and liquids), topicals (creams and ointments) for both exports as well as Pharamceuticals
domestic markets.
Investment Amount
NCD – INR 250 crore
Credit Updates
Total Tenor
Healthy revenue growth registered over 9 months of FY22 driven primarily by growth
3 years
in India business and UK vaccination orders
Revenues registered a 21% yoy growth over 9MFY22 for Wockhardt Limited (“the Company”) Average Maturity
2.5 years
driven primarily by the growth in India chronic business and UK vaccine business of the
company. Repayment Type
The chronic segment drove the growth in the India business. Sales from India vaccine Amortizing
business (Sputnik V) are yet to take-off and sales from the same should add further to Security
revenues. Exclusive charge
Orders from the UK government for COVID-19 vaccines led to growth in UK business, along over shares of
Wockhardt Limited,
with the resumption of the non-vaccine business, which were closer to pre-pandemic levels.
and
Revenues remained flat QoQ as moderate declines in India and UK business in Q3FY22 were Pari passu charge
compensated by a strong performance in emerging markets, which had seen a few lacklustre over Fixed assets of
the company
quarters and strong turnaround in US business post management revamp.
Chart 1 Quarterly sales break up by geography
Security Cover: 2x
Geography wise sales
1,000
900
800
Revenue (INR cr)
700
600
500
400
300
200
100
-
The Company has entered into a contract with Enso Healthcare (Russian Direct Investment
Fund’s coordination partner for sourcing Sputnik vaccine in India) and a subsidiary of Russian
Direct Investment Fund for manufacturing and supply of 620 million doses of Sputnik V and
the Sputnik Light vaccines. As per this order, the Company has to provide 70-120 million
doses by June 2022 and has the option to enter an agreement to supply an additional 500
million doses subsequently. The Company now expects offtakes to take place from Q3 FY23.
However, actual order offtakes and receipt of payments against the same will remain a key
monitorable.
Long-term tie-up with Serum Institute for production of Serum’s vaccines in UK
Page 7 of 17
Stricly Private & Confidential
During 9MFY22, there has been a significant improvement in profitability over the corresponding
previous. Higher volumes in India and higher sales from UK vaccine business, which is a very
high margin business, led to higher gross margins.Constant overhead costs combined with
higher sales led to higher operating profitability on account of high operating leverage in the
business.
However, higher interest costs resulted in a negative PAT for the company for 9MFY22. Net
losses reduced significantly over 9MFY21 indicating an ongoing turnaround in business
performance. Offtake of Sputnik vaccine manufacturing in India and performance of UK
business post completion of contract to manufacture Covid-19 vaccine will remain a key
monitorable determining profitability going forward.
Total debt was stable between March and September 2021, despite healthy cashflow from
operations, which was used for capex and expenditure for the vaccine project. There has been
a significant reduction in external debt over the last couple of years through scheduled
maturities.
4000
Term Debt (INR crore)
3000
2000
1000
0
Mar-17 Mar-18 Mar-19 Mar-20 Mar-21 Sep-21 Dec-21
Page 8 of 17
Stricly Private & Confidential
The company has also successfully raised INR 748 crore through a rights issue, wherein shares
were allotted at INR 225, at significant discount to the prevailing market prices. The proceeds
of the rights issue will be used towards partrepayment of subordinated debt (from promoters)
and towards funding R&D expenditure. Part repayment of subordinated debt would improve the
bottom line by reducing interest expense.
Our view
The delay in off take of the Sputnik vaccine business (inherently a high margin business)
might put pressure on the margins
The Company has already incurred capex for the vaccine project and any delay in revenue
generation will impact the debt coverage metrics, thereby exposing the company to refinance
risk
The recently concluded rights issue will help the company deleverage to some extent and
provide working capital which is credit positive
Security Until the 1.0x security cover through pari-passu charge over fixed assets
is not perfected, 1.0x security cover will be provided by equity shares of
Wockhardt Limited. This 1.0x will be released within 2 days once the
charge over fixed assets is perfected.
Compliances (ii) Due to the recent volatility in the markets, there have been multiple
triggers for share top-ups. The Company has been generally compliant on
all such occasions
Page 9 of 17
Stricly Private & Confidential
(mn sft)
14.50 9.40
14.00 9.20 Key Security
13.50 9.00
13.00 8.80 Pledge over shares
12.50 8.60 of NDR Plantations
12.00 8.40 Private Limited
Corporate Guarantee
from NDR Plantations
Private Limited
Diversified Portfolio – Location and Tenant Breakdown as of 31st March 2022
Pondicherry Aurangabad
Mumbai (West) (South) (West)
11% 1% 2% Bangalore Security Cover
(South)
Kolkata (East) 9% Total Security
3%
Cover – 2.00x
Gurgaon (North)
7%
Coimbatore
(South)
18% Chennai (South)
49%
IT/ITES Steel
FMCG 3% 1%
4% Retail
3%
Automobile
5%
3PL
E Commerce 45%
17%
CFS
10% Textile
12%
The Company’s area under lease has gradually increased over the last few months
driven by operationalization of a few new warehouses leased out to Amazon, Croma,
Lifestyle, etc. Improvement in revenues were also achieved as a result of better
utilization of space, including usage of common areas and open spaces
Recently, the company has incrementaly signed up new LOIs with clients such as
Flipkart (0.6 mn sqft in Kolkata) and Reliance (0.02 mn sqft in New Delhi). The tenor
of the leases is ~15 years
Page 10 of 17
Stricly Private & Confidential
The company has plans to ramp up its current capacity from ~10 m sft to around 19.5
m sft over the next 2 years (FY23 and FY24). Once complete, it would be one of the
top five warehousing platforms in India and would get the assets listed through a
REIT/ InVIT listing in the stock exchanges.
Consolidated portfolio rentals expected to increase from ~INR 180 Crore (basis
current monthly rental run rate of ~ INR 15 Crore) to ~INR 434 Crore by FY25
Page 11 of 17
Stricly Private & Confidential
Kalpataru Group was established in 1969 and is a diversified conglomerate with interest in Real
Estate, Power Transmission, and EPC in major infrastructure segments like Power
Transmission and Distribution, Buildings & Factories, Roads & Highways, Water & Irrigation,
Railways and Oil and Gas. Investment Date
December- January 2022
Kalpataru Power Transmission Limited (KPTL) is amongst the leading Engineering,
Procurement, and Construction (EPC) companies with over four decades of operations. KPTL
delivers complete solutions covering design, testing, fabrication, erection and construction of
transmission lines, oil and gas infrastructure and railways projects on a turnkey basis. KPTL Sector
has established its footprints in 63 countries spread across five continents. Power Transmission
Kalpataru Ltd and Kalpataru Properties Private Limited are the flagship entities of the real estate
arm of the Kalpataru Group. Investment Amount
NCD - INR 70 crore
The group is amongst the leading real estate developers in MMR with a presence across
segments like premium residential, commercial, retail, integrated townships, lifestyle gated
communities and redevelopment projects primarily in the Mumbai Metropolitan Region (MMR)
and Pune. Average Maturity
36 months
The Fund has made investment in NCDs issued by Kalpataru Properties Private Limited. The
proceeds were used for capitalization of various businesses in the group and long term working
capital purposes and repayment of existing debt in group. Repayment Type
Amortizing over the
Tenor
Page 12 of 17
Stricly Private & Confidential
Standalone Consolidated
INR crore 9MFY21 9MFY22 9MFY21 9MFY22
Income Statement
Revenue from operations 5,334 5,052 8,863 10,642
YOY (%)
Construction Expense 3,836 3,717 6,326 7,858
Gross Profit 1,498 1,335 2,537 2,784
Margin (%) 28.0% 26.4% 28.6% 26.1%
Investment Rationale
Pedigreed and reputed group: Kalpataru group has been in various businesses for more
than four decades and is a well-established and a diversified corporate. Transaction
structure: The NCD facility is secured by exclusive pledge over the shares of KPTL which
is rated CRISIL AA and has a strong credit profile
KPTL is one of the leading players in this space, with reputed customers such as Power
Grid Corporation of India Ltd (‘CRISIL AAA/FAAA/Stable/CRISIL A1+’) and various state
transmission utilities. Order book of INR 31,000 crore at consolidated level as on September
30, 2021, provides strong revenue visibility over the medium term.
Diversified revenue: While the flagship company, KPTL, contributes 67% to total revenue;
32% comes from JMC, which executes projects in the infrastructure, industrial and
commercial building, railway, and road segments. The balance 1% of consolidated revenue
primarily comes from SSL, which provides warehousing and logistics services. About 27%
of the total unexecuted orders are from the international market. Exports are primarily to
countries in Asia, Africa, Central and Latin America, the Middle East, Australia, and Europe.
Diversified revenue streams help reduce susceptibility to downturns in any one business.
Outlook on KPTL
The operations are doing well with robust order inflow. This gives good revenue visibility
and with sustained improvement in operating margin, cash generation will be higher which
should further reduce debt
Divestment of its non-core assets i.e T&D BOT assets, Real Estate Project will help to further
delever the balance sheet
Page 13 of 17
Stricly Private & Confidential
Investment Description
Strong backing by marquee private equity players – Jana Small Finance Bank is
backed by marquee private equity like TPG, GIC, Morgan Stanley, Harborvest and many Average Maturity
other large investors. These private equity funds own stake both in the bank as well as in 27 months; prepaid in
JCL. The bank has a strong board of directors. The shareholders have demonstrated their March 2022
support to the business repeatedly by infusing capital across the bank and the holding
companies.
Short term special situation opportunity – JHL had raised debt through NCDs in 2018, Repayment Type
part of which (INR 155 crore face value, INR 245 crore maturity value) has matured recently Bullet at maturity
and JHL has refinanced the same through debt raised from new and existing investors.
The Fund has invested in INR 40 crore in the aforementioned issuance.
The company is already in discussions for a large fund raise from a strategic investor to Key Security
refinance the outstanding debt. Hence, the Fund has investred in this transaction purely as Pledge over shares of
Jana Small Finance
a short term special situation investment.
Bank
Transaction structure – The NCDs are secured by a fixed number of shares of Jana Small Pledge over shares of
Finance Bank and Jana Capital Limited Jana Capital Limited
Outlook
The bank has been growing its loan book very cautiously reflected in the healthy asset
quality and increasing share of secured assets. The loan growth moderated in FY21 on
account of the company taking a conservative approach in wake of COVID-19
The bank has already filed its draft red herring prospectus and is expected to get listed
soon
Credit Update
Page 14 of 17
Stricly Private & Confidential
The Adventz Group is into multiple businesses ranging from fertilizers, engineering, real estate
and sugar. Zuari Global Limited (“ZGL”) is the holding company of Adventz Group.
Zuari Agrochemicals Private Limited (“ZACL”) through its subsidiaries and joint ventures is
engaged in manufacturing of fertilizers, seeds, and other agri-inputs. ZACL is engaged in
Investment Date
manufacturing of urea as well as DAP/NPK fertilizers at its Goa manufacturing facility along
February- April 2022
with water soluble fertilizers (WSF) and Single Super Phosphate (SSP) manufactured at other
plants of the company.
Sector
The Fund has invested in NCDs issued by Zuari Agrochemicals Private Limited. The proceeds Fertilizer
were used for repayment of existing debt and align the debt repayment as per cash flows.
Investment Rationale
Investment
Positive Sector Outlook: Amount
Indian soil remains deficient in nutrient content, which has resulted in lower agri- NCD (till March 31st,
productivity. With increasing population, the demand for food will increase which will 2022) INR 90 crore
make productivity improvement imperative for the agri sector. Thus, the demand
outlook for fertilizers remains positive in India
There has been a significant uptick in this sector largely driven by GoI policymaking.
Reduction towards import of Ammonia, Urea and facilitating has resulted in anincrease Average Maturity
in domestic manufacturing in these products. With the Urea self-sufficiency plan of GoI 36 months
by 2023, India will become self-sufficient in Urea with negligible or no imports.
However, ample opportunities will be available for the industry for non-Urea fertilisers Coupon Frequency:
like DAP and other Complex fertilisers. GoI is also providing impetus on balanced use Annual
of fertilizers which is expected to give rise in the demand of DAP and other complex
fertilizers and result in reduction in the demand of Urea
Transaction structure: The NCD facility is secured by exclusive pledge over the Repayment Type
shares of MCFL which is rated CARE BBB+ and has a strong credit profile Amortizing over the
Tenor
Established position and wide customer base: MCFL is one of the leading companies
catering to the fertilizer markets in Southern India. About 72% of MCFL’s products Key Security
are sold in the state of Karnataka, which meets about 11% of the needs of the Pledge over
farmers in the state. MCFL also maintains good market share in Kerala and a modest shares of MCFL
share in neighboring states of Tamil Nadu, Andhra Pradesh, Telangana and
Maharashtra.
MCFL is an integrated manufacturer and trader of fertilizers, with manufacturing
facility at Panambur, Mangalore, and Karnataka. The plant is located at Mangalore
West Coast, close to Mangalore port. The total installed capacity is 6.815 lac MT with Exclusive
key products being urea, NPK and other complex fertilizers. The main products are Security Cover:
urea, di ammonium phosphate (DAP), NP, muriate of potash (MOP), speciality 2.00x
fertilizers consisting of water soluble fertilizers and micronutrients, plant nutrition
products such as soil conditioners and industrial products, viz., ammonium bi-
carbonate, sulfonated naphthalene formaldehyde, etc.
Higher operational efficiency and EBITDA: (i) post conversion of plant from Naptha
to Gas. (ii) Energy Improvement Project (EIP) to further improve efficiency, leading
to better margins
The above improvement in energy consumption is expected to add incremental ~INR
150-180 crore/pa in EBITDA from Urea manufacturing till December 14, 2025
Favourable Government policies augurs well: Fertilizer industry is highly regulated
and with an aim to boost investments, GoI has initiated policy steps that could
structurally improve fertiliser industry’s dynamics with schemes like gas price
pooling, DBT, NPS III, Modified NPS III, New Investment Policy, and New Urea
policy.
Payable of subsidy by GoI in a timely manner results in significant reduction of
working capital cycle and thus can improve the profitability of MCFL
Page 15 of 17
Stricly Private & Confidential
Page 16 of 17
Stricly Private & Confidential
Disclaimer:
This document has been prepared for general information only and should not be construed as an offer or solicitation of an offer or advice for
purchase of any units/ securities/ instruments/ products or any other financial products. The information and statistical data contained herein is
proprietary or extracted from publicly available information or other sources which are believed to be reliable, but in no way warrants to its accuracy
or completeness. Market views/ outlook (if any) expressed herein are for general information only and do not have regards to any specific
investment objectives, financial situation and the particular needs of any specific person who may have received this information. It should not be
construed as an investment advice to any party. These views/ outlook/ information alone are not sufficient and should not be used for the
development or implementation of any strategy. Recipients of this document / information must rely upon its/ his/ her own representatives, including
its/ his/ her own advisers and accountants. Recipient should also understand that any reference to the units/ schemes/ securities/ instruments/
sectors in this document is only for illustration purpose and are NOT recommendations. All opinions and estimates (if any) included herein are
subject to change without notice. Any projections, forecasts and estimates contained in this document are necessarily speculative in nature and
are based upon certain assumptions. This document may contain forward-looking statements in which case the recipient of this document or
information contained therein should understand that statements made herein regarding future prospects may not be realized. Any performance
information shown in the document refers to the past and should not be seen as an indication of future returns. No assurance is given guarantee
for any accuracy of any of the facts or interpretations in this document. The information provided in this document is not intended for solicitation
to, invitation to, or offer to, any person in any jurisdiction or country where such solicitation, invitation or offer would be contrary to law or regulation.
You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this material/ information
contained in it is strictly prohibited and may be unlawful.
Page 17 of 17